Similar articles for PMID: 30562637

Year	Number of Results
2001	1
2003	1
2004	2
2005	5
2006	6
2007	7
2008	2
2009	7
2010	19
2011	8
2012	4
2013	9
2014	13
2015	8
2016	13
2017	6
2018	7
2019	7
2020	5
2021	5
2022	2
2023	1

1

Association of CHFR Promoter Methylation with Treatment Outcomes of Irinotecan-Based Chemotherapy in Metastatic Colorectal Cancer.

Cha Y, Kim SY, Yeo HY, Baek JY, Choi MK, Jung KH, Dong SM, Chang HJ. Cha Y, et al. Neoplasia. 2019 Jan;21(1):146-155. doi: 10.1016/j.neo.2018.11.010. Epub 2018 Dec 15. Neoplasia. 2019. PMID: 30562637 Free PMC article.

2

CHFR-Promoter-Methylation Status Is Predictive of Response to Irinotecan-based Systemic Chemotherapy in Advanced Colorectal Cancer.

Hagiwara T, Sugimoto K, Momose H, Irie T, Honjo K, Okazawa YU, Kawai M, Kawano S, Munakata S, Takahashi M, Kojima Y, Serizawa N, Nagahara A, Hoffman RM, Brock MV, Sakamoto K. Hagiwara T, et al. Anticancer Res. 2022 Feb;42(2):697-707. doi: 10.21873/anticanres.15528. Anticancer Res. 2022. PMID: 35093868

3

A phase 2 trial of gemcitabine and docetaxel in patients with metastatic colorectal adenocarcinoma with methylated checkpoint with forkhead and ring finger domain promoter and/or microsatellite instability phenotype.

Baretti M, Karunasena E, Zahurak M, Walker R, Zhao Y, Pisanic TR 2nd, Wang TH, Greten TF, Duffy AG, Gootjes E, Meijer G, Verheul HMW, Ahuja N, Herman JG, Azad NS. Baretti M, et al. Clin Transl Sci. 2021 May;14(3):954-963. doi: 10.1111/cts.12960. Epub 2021 Apr 3. Clin Transl Sci. 2021. PMID: 33811727 Free PMC article. Clinical Trial.

4

WRN Promoter CpG Island Hypermethylation Does Not Predict More Favorable Outcomes for Patients with Metastatic Colorectal Cancer Treated with Irinotecan-Based Therapy.

Bosch LJ, Luo Y, Lao VV, Snaebjornsson P, Trooskens G, Vlassenbroeck I, Mongera S, Tang W, Welcsh P, Herman JG, Koopman M, Nagtegaal ID, Punt CJ, van Criekinge W, Meijer GA, Monnat RJ Jr, Carvalho B, Grady WM. Bosch LJ, et al. Clin Cancer Res. 2016 Sep 15;22(18):4612-22. doi: 10.1158/1078-0432.CCR-15-2703. Epub 2016 Apr 27. Clin Cancer Res. 2016. PMID: 27121793 Free PMC article.

5

CHFR silencing or microsatellite instability is associated with increased antitumor activity of docetaxel or gemcitabine in colorectal cancer.

Pelosof L, Yerram SR, Ahuja N, Delmas A, Danilova L, Herman JG, Azad NS. Pelosof L, et al. Int J Cancer. 2014 Feb 1;134(3):596-605. doi: 10.1002/ijc.28390. Epub 2013 Aug 24. Int J Cancer. 2014. PMID: 23873170 Free PMC article.

6

Predictive value of CHFR and MLH1 methylation in human gastric cancer.

Li Y, Yang Y, Lu Y, Herman JG, Brock MV, Zhao P, Guo M. Li Y, et al. Gastric Cancer. 2015 Apr;18(2):280-7. doi: 10.1007/s10120-014-0370-2. Epub 2014 Apr 21. Gastric Cancer. 2015. PMID: 24748501 Free PMC article.

7

Phase II study of nab-paclitaxel in refractory small bowel adenocarcinoma and CpG island methylator phenotype (CIMP)-high colorectal cancer.

Overman MJ, Adam L, Raghav K, Wang J, Kee B, Fogelman D, Eng C, Vilar E, Shroff R, Dasari A, Wolff R, Morris J, Karunasena E, Pisanic TR 2nd, Azad N, Kopetz S. Overman MJ, et al. Ann Oncol. 2018 Jan 1;29(1):139-144. doi: 10.1093/annonc/mdx688. Ann Oncol. 2018. PMID: 29069279 Free PMC article. Clinical Trial.

8

CpG island methylation, response to combination chemotherapy, and patient survival in advanced microsatellite stable colorectal carcinoma.

Ogino S, Meyerhardt JA, Kawasaki T, Clark JW, Ryan DP, Kulke MH, Enzinger PC, Wolpin BM, Loda M, Fuchs CS. Ogino S, et al. Virchows Arch. 2007 May;450(5):529-37. doi: 10.1007/s00428-007-0398-3. Epub 2007 Mar 20. Virchows Arch. 2007. PMID: 17372756

9

Adverse prognostic impact of the CpG island methylator phenotype in metastatic colorectal cancer.

Cha Y, Kim KJ, Han SW, Rhee YY, Bae JM, Wen X, Cho NY, Lee DW, Lee KH, Kim TY, Oh DY, Im SA, Bang YJ, Jeong SY, Park KJ, Kang GH, Kim TY. Cha Y, et al. Br J Cancer. 2016 Jul 12;115(2):164-71. doi: 10.1038/bjc.2016.176. Epub 2016 Jun 16. Br J Cancer. 2016. PMID: 27310704 Free PMC article.

10

Promoter methylation of CHFR gene in gastric carcinoma tissues detected using two methods.

Cheng ZD, Hu SL, Sun YB, Xu WP, Shen G, Kong XY. Cheng ZD, et al. Chin J Cancer. 2010 Feb;29(2):163-6. doi: 10.5732/cjc.009.10305. Chin J Cancer. 2010. PMID: 20109344 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

121 results

Results by year